Literature DB >> 16702387

The influence of statin use on breast density.

Denise M Boudreau1, Carolyn M Rutter, Diana S M Buist.   

Abstract

OBJECTIVE: To evaluate if 3-hydroxy-3-methylglutaryl CoA reductase reductase inhibitor use (statins) alters mammography measured breast density.
METHODS: Cohort study of women ages 50 to 80 years with two mammography screenings. Changes in BI-RADS breast density between screenings was compared for nonusers, initiators, discontinuers, continuers, and any users of statins.
RESULTS: Statin use was not associated with increases or decreases in breast density compared with nonusers after adjusting for age, body mass index, change in body mass index, hormone therapy use, and time between screenings. Cumulative days of statin use during the year before screening was not associated with changes in breast density in any of the groups of statin users. When hormone therapy users were excluded, any statin use was associated with an increase in breast density compared with nonusers (odds ratio, 1.2; 95% confidence interval, 1.0-1.5).
CONCLUSIONS: We found no association between statin use and change in breast density in general, but statin use may be associated with increases in breast density among nonusers of hormone therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702387      PMCID: PMC2066203          DOI: 10.1158/1055-9965.EPI-05-0802

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

1.  Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women.

Authors:  Erin J Aiello; Shelley S Tworoger; Yutaka Yasui; Frank Z Stanczyk; John Potter; Cornelia M Ulrich; Melinda Irwin; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

2.  Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories.

Authors:  S Ciatto; N Houssami; A Apruzzese; E Bassetti; B Brancato; F Carozzi; S Catarzi; M P Lamberini; G Marcelli; R Pellizzoni; B Pesce; G Risso; F Russo; A Scorsolini
Journal:  Breast       Date:  2005-08       Impact factor: 4.380

3.  Mammographic breast density and cancer risk: the radiological view.

Authors:  Martin Yaffe; Norman Boyd
Journal:  Gynecol Endocrinol       Date:  2005-07       Impact factor: 2.260

Review 4.  Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.

Authors:  James M McKenney
Journal:  Am J Cardiol       Date:  2005-08-22       Impact factor: 2.778

5.  Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study.

Authors:  Anne-Sofie Furberg; Grazyna Jasienska; Nils Bjurstam; Peter A Torjesen; Aina Emaus; Susan F Lipson; Peter T Ellison; Inger Thune
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

6.  Plasma lipids, lipoproteins, and mammographic densities.

Authors:  N F Boyd; P Connelly; J Byng; M Yaffe; H Draper; L Little; D Jones; L J Martin; G Lockwood; D Tritchler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Oct-Nov       Impact factor: 4.254

7.  Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population.

Authors:  S H Taplin; M T Mandelson; C Anderman; E White; R S Thompson; D Timlin; E H Wagner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-08       Impact factor: 4.254

8.  Macronutrient intake and change in mammographic density at menopause: results from a randomized trial.

Authors:  J A Knight; L J Martin; C V Greenberg; G A Lockwood; J W Byng; M J Yaffe; D L Tritchler; N F Boyd
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-02       Impact factor: 4.254

9.  Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.

Authors:  G A Greendale; B A Reboussin; A Sie; H R Singh; L K Olson; O Gatewood; L W Bassett; C Wasilauskas; T Bush; E Barrett-Connor
Journal:  Ann Intern Med       Date:  1999-02-16       Impact factor: 25.391

10.  Are breast density and bone mineral density independent risk factors for breast cancer?

Authors:  Karla Kerlikowske; John Shepherd; Jennifer Creasman; Jeffrey A Tice; Elad Ziv; Steve R Cummings
Journal:  J Natl Cancer Inst       Date:  2005-03-02       Impact factor: 13.506

View more
  3 in total

1.  Statin use and breast cancer risk in a large population-based setting.

Authors:  Denise M Boudreau; Onchee Yu; Diana L Miglioretti; Diana S M Buist; Susan R Heckbert; Janet R Daling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

2.  Medication use and mammographic breast density.

Authors:  Yunan Han; Chee Teik Lee; Shuai Xu; Xiaoyue Mi; Courtnie R Phillip; Ana S Salazar; Malika Rakhmankulova; Adetunji T Toriola
Journal:  Breast Cancer Res Treat       Date:  2021-07-01       Impact factor: 4.624

3.  Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density.

Authors:  Erica J Lee Argov; Teofilia Acheampong; Mary Beth Terry; Carmen B Rodriguez; Mariangela Agovino; Ying Wei; Shweta Athilat; Parisa Tehranifar
Journal:  Breast Cancer Res       Date:  2020-09-15       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.